ArticleMolecular therapy oncolytics2022

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity.

Jack Y Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.